Biohub researchers use artificial intelligence to uncover new psoriasis targets - News-Medical
Researchers at Biohub have used AI to identify novel biological targets for psoriasis, potentially accelerating drug discovery.
- AI identified novel biological targets for psoriasis by analyzing large-scale genetic and clinical datasets.
- The study demonstrates AI's potential to accelerate drug discovery for complex inflammatory diseases.
- Researchers aim to develop more effective, personalized treatments based on AI-driven insights.
- The findings highlight the growing intersection of AI and biomedical research in addressing chronic conditions.
A team of researchers at the Chan Zuckerberg Biohub has applied artificial intelligence to analyze vast datasets, uncovering previously unknown biological pathways involved in psoriasis. The study, published in a peer-reviewed journal, highlights how machine learning models can sift through genetic, clinical, and molecular data to pinpoint targets that traditional methods might miss. By focusing on these new targets, scientists aim to develop more effective and personalized treatments for the chronic inflammatory skin condition, which affects millions worldwide.
The breakthrough underscores the growing role of AI in drug discovery, particularly in complex diseases like psoriasis where multiple factors contribute to pathology. Unlike conventional approaches that rely on trial-and-error or limited experimental data, AI-driven methods can process enormous datasets to identify correlations and potential therapeutic avenues. This work could pave the way for faster, more precise drug development pipelines, reducing both time and costs associated with bringing new treatments to market.
Source: Biohub researchers use artificial intelligence to uncover new psoriasis targets - News-Medical. Read the full piece at the source.
Opportunities to build or refine AI models for biomedical data analysis and drug target identification.
Potential for pharmaceutical companies to leverage AI-driven insights for faster, cost-effective drug development.
Emerging investment opportunities in AI-powered drug discovery platforms and biotech startups.
Insight into the application of AI in biomedical research and its impact on future healthcare solutions.
- Psoriasis
- A chronic autoimmune skin condition causing red, scaly patches on the skin.
- Biological targets
- Specific molecules or pathways in the body that drugs can interact with to treat disease.
AI ResearchI Built a Self-Improving AI, and So Can You
USC researchers develop low-cost AI tool to help cities map urban tree canopy - USC Today
‘We also need to talk about artificial intelligence's positive potential,' says AI for Good founder - Geneva Solutions
AI ResearchWhy this CEO thinks video games make better training data than the internet
Data for Agents
Alphabet's Artificial Intelligence (AI) Spending Spree Is Great News for Nvidia - The Motley Fool
Alphabet's increased AI spending is expected to benefit Nvidia's business, according to The Motley Fool.
AI ToolsNetflix AI Team Cuts Wide-Partition Read Latency from Seconds to Milliseconds by Splitting Cassandra Partitions Per ID
Netflix’s AI team reduced Cassandra partition read latency from seconds to tens of milliseconds by dynamically splitting oversized partitions per TimeSeries ID.
SecurityGoogle’s deepfake detector system used to debunk McConnell hoax pic
Google's deepfake detection system successfully identified and debunked a fabricated image of Senator Mitch McConnell circulating online.
FTC Proposes New Policy on AI Accuracy: Hiding How an AI System is Steered May Violate Federal Law - Spencer Fane
The U.S. FTC proposes a policy stating that failing to disclose how AI systems are guided may violate federal law, signaling stricter oversight of AI transparency.
Quoting Kenton Varda
A senior engineer halted AI-written pull request descriptions, citing they added no value and obscured code context.
NEWSLETTER: China weighs silicon curtain around sought-after AI models - Reuters
China is reportedly exploring a 'silicon curtain' policy to limit exports of advanced AI chips, potentially reshaping global AI hardware access.